These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
25. Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome. Hong CH; Ko MS; Kim JH; Cho H; Lee CH; Yoon JE; Yun JY; Baek IJ; Jang JE; Lee SE; Cho YK; Baek JY; Oh SJ; Lee BY; Lim JS; Lee J; Hartig SM; Conde de la Rosa L; Garcia-Ruiz C; Lee KU; Fernández-Checa JC; Choi JW; Kim S; Koh EH Cell Mol Gastroenterol Hepatol; 2022; 13(3):925-947. PubMed ID: 34890841 [TBL] [Abstract][Full Text] [Related]
26. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. Ponnusamy S; Tran QT; Thiyagarajan T; Miller DD; Bridges D; Narayanan R Exp Biol Med (Maywood); 2017 Mar; 242(6):606-616. PubMed ID: 28092182 [TBL] [Abstract][Full Text] [Related]
27. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616 [TBL] [Abstract][Full Text] [Related]
28. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling. Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025 [TBL] [Abstract][Full Text] [Related]
29. Elovl6 promotes nonalcoholic steatohepatitis. Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171 [TBL] [Abstract][Full Text] [Related]
30. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement. Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788 [TBL] [Abstract][Full Text] [Related]
31. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027 [TBL] [Abstract][Full Text] [Related]
32. Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity. Han JH; Shin H; Rho JG; Kim JE; Son DH; Yoon J; Lee YJ; Park JH; Song BJ; Choi CS; Yoon SG; Kim IY; Lee EK; Seong JK; Kim KW; Kim W Diabetes Obes Metab; 2018 Sep; 20(9):2179-2189. PubMed ID: 29740969 [TBL] [Abstract][Full Text] [Related]
33. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis. Kim B; Farruggia C; Ku CS; Pham TX; Yang Y; Bae M; Wegner CJ; Farrell NJ; Harness E; Park YK; Koo SI; Lee JY J Nutr Biochem; 2017 May; 43():27-35. PubMed ID: 28193580 [TBL] [Abstract][Full Text] [Related]
34. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function. Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164 [TBL] [Abstract][Full Text] [Related]
35. Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b(+) macrophages. De Boer AA; Monk JM; Liddle DM; Hutchinson AL; Power KA; Ma DW; Robinson LE J Nutr Biochem; 2016 Aug; 34():61-72. PubMed ID: 27208584 [TBL] [Abstract][Full Text] [Related]
36. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299 [TBL] [Abstract][Full Text] [Related]
38. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation. Sui YH; Luo WJ; Xu QY; Hua J World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141 [TBL] [Abstract][Full Text] [Related]
39. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Ni Y; Nagashimada M; Zhuge F; Zhan L; Nagata N; Tsutsui A; Nakanuma Y; Kaneko S; Ota T Sci Rep; 2015 Nov; 5():17192. PubMed ID: 26603489 [TBL] [Abstract][Full Text] [Related]
40. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet. Zhu W; Feng PP; He K; Li SW; Gong JP Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]